GlobeNewswire·Nov 12, 2026, 6:18 PM ET

Windward Bio Announces Pricing of Initial Public Offering

Windward Bio Group AG priced its initial public offering of 10,294,117 common shares at $17.00 per share.
Underwriters received a 30-day option to purchase up to an additional 1,544,117 common shares.
Gross proceeds from the IPO & concurrent private placement are expected to be $225.0 million before expenses.
Windward sold 1,532,691 common shares & pre-funded warrants for 1,408,485 shares to Sanofi Foreign Participations B.V. for $50.0 million in a concurrent private placement.
Shares are expected to begin trading on the Nasdaq Global Select Market on November 13, 2026, under the symbol "WWB".
The offering is scheduled to close on November 16, 2026, subject to customary conditions.
Jefferies, TD Cowen, Piper Sandler, & UBS Investment Bank are acting as joint book-running managers.
The registration statement was declared effective on November 12, 2026, & copies of the final prospectus are available through the managing underwriters.
The private placement closing is contingent on the consummation of the initial public offering, but the IPO is not contingent on the private placement.